跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gafvex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gafvex
Approved
STANDARD
Gafvex
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6015961252d4e830
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
6015961252d4e830
Drug Approval Philippines Name
Gafvex
Product Name
Gafvex
Registration Number
DR-XY44664
Brand Name
Gafvex
Generic Name
Gefitinib
Dosage Form
Film-Coated Tablet
Dosage Strength
250mg
Manufacturer
Admac Lifesciences
Importer
VE Pharma, Inc.
Distributor
VE Pharma, Inc.
Issuance Date
24 January 2025
Expiry Date
22 June 2030
Pharmacologic Category
Antineoplastic (Protein Kinase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6015961252d4e830
Type
Standard
Back to Philippines FDA Approvals